0001399529-21-000062.txt : 20210405
0001399529-21-000062.hdr.sgml : 20210405
20210405213657
ACCESSION NUMBER: 0001399529-21-000062
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Bob D
CENTRAL INDEX KEY: 0001598479
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 21807955
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER NAME:
FORMER CONFORMED NAME: Brown Bob
DATE OF NAME CHANGE: 20140129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4/A
1
wf-form4a_161767292102255.xml
FORM 4/A
X0306
4/A
2021-02-03
2021-02-04
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001598479
Brown Bob D
C/O DICERNA PHARMACEUTICALS, INC.
75 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Scientific Ofr., EVP R&D
Common Stock
2021-02-03
4
M
0
3066
3.42
A
24583
D
Common Stock
2021-02-03
4
M
0
5246
2.97
A
29829
D
Employee Stock Option (Right to Buy)
3.42
2021-02-03
4
M
0
3066
0
D
2023-09-24
Common Stock
3066.0
74808
D
Employee Stock Option (Right to Buy)
2.97
2021-02-03
4
M
0
5246
0
D
2027-01-03
Common Stock
5246.0
0
D
The Reporting Person's original Form 4 as filed with the Securities and Exchange Commission on February 4, 2021 (the "Original Form 4") is hereby amended to reflect the correct option grants from which the shares were exercised. The aggregate total number of shares exercised (8,312 shares) was correctly reported in the Original Form 4. Except as noted in this amended Form 4, all other information disclosed in the Original Form 4 was accurately reported and remains unchanged.
As of the transaction date, the option was fully vested. The option vested 1/48 monthly on the last day of each month with the vesting start date of 7/30/2013.
The option vests in 48 monthly installments over the four-year period starting on the last day of January 2017, subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date.
/s/ Douglas W. Pagan, attorney-in-fact
2021-04-05